Stay updated on Orally Administered AG-120 in Hematologic Malignancies Clinical Trial
Sign up to get notified when there's something new on the Orally Administered AG-120 in Hematologic Malignancies Clinical Trial page.

Latest updates to the Orally Administered AG-120 in Hematologic Malignancies Clinical Trial page
- CheckyesterdayChange DetectedThe web page has been updated to reflect the upcoming modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an invitation for API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.SummaryDifference6%
- Check8 days agoChange DetectedThe web page has been updated to version 2.16.0, replacing the previous version 2.15.2.SummaryDifference1.0%
- Check16 days agoNo Change Detected
- Check30 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.3%
- Check44 days agoChange DetectedThe web page has been updated to reflect a new version, changing from v2.14.4 to v2.15.0.SummaryDifference1.0%
- Check52 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.3%
- Check95 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference5%
Stay in the know with updates to Orally Administered AG-120 in Hematologic Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Orally Administered AG-120 in Hematologic Malignancies Clinical Trial page.